|1.25||0.00 / 0.00%|
Data as of Aug 19
|1.05||-0.20 / -16.00%|
The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 2.38, with a high estimate of 2.50 and a low estimate of 2.25. The median estimate represents a +90.00% increase from the last price of 1.25.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.